Agenda Packets - 2020/05/04 - Laserfiche WebLink

Home Browse Search

*City of Mounds View* DOT Drug -Free Workplace Policy 2020 Version 15 telephone drivers at the numbers given on the CCF. If a driver believes a mistake was made at the collection site or lab, or on a CCF, or that the drug test result is caused by lawful substance use, the driver should tell the MRO. Drivers should cooperate with the MRO. If a driver does not cooperate, the Company will be notified and the driver may be removed from duty and disciplined or discharged pursuant to the Company’s independent authority (or not hired, if the driver is an applicant). 10. If a driver wants his or her split specimen to be tested by another certified lab at the driver’s expense, the driver should tell the MRO within 72 hours of notice of a positive, adulterated or substituted drug test result. The driver will not have the opportunity to provide another specimen. The retest will be conducted on the secondary container of the original specimen. The driver’s secondary specimen will then be sent to a different Company-approved, certified laboratory for re-analysis. If that second lab does not find any evidence of the drug(s) that the first lab found or the split specimen cannot be tested, the MRO will cancel the test results and the driver will not be subject to discipline. If the second laboratory finds evidence of the drugs, adulteration or substitution that the first laboratory found, the MRO will tell the DER the split specimen was positive, adulterated or substituted. As provided in 49 CFR § 40.187(a)(3), in the case of a reconfirmed substituted result in which the creatinine concentration for the primary specimen was less than 2 mg/dL and the creatinine concentration of the split specimen is between 2 and 5 mg/dL (inclusive), the MRO will report the result as "dilute" and the driver will be required to undergo an immediate recollection under direct observation. 11. If the MRO informs the Company that a negative drug test was dilute, the following will apply. • Dilute Negative with Low Creatinine: If the MRO indicates that a recollection under direct observation is required because the creatinine concentration of the specimen was equal to or greater than 2 mg/dL but less than or equal to 5 mg/dL, the Company must immediately instruct the driver to undergo a recollection under direct observation. The DOT's stated purpose for this requirement is so that people who may naturally produce low creatinine levels will not be reported to employers as having substituted their specimens. The DOT prohibits any driver who has a verified positive, adulterated or substituted drug test result, from performing or from continuing to perform a safety-sensitive function until he/she has met the proper DOT requirements as described in the “Post-Violation/Return-to-Duty Procedures” section above under Consequences for Policy Violations. Medications prescribed for someone other than the driver, will be considered unlawfully used under any circumstance. The DOT also indicates that a driver’s purported use of marijuana for medical purposes (even if pursuant to state “medical marijuana” law) or use of hemp or marijuana-related products does not constitute a legitimate medical explanation for a positive test result and these are insufficient grounds for the MRO to verify the test result as negative. EDUCATION AND TRAINING The Company has available information, education and training regarding problems associated with drug and alcohol abuse in the workplace and otherwise. One important source of information is the “Employee Handbook.” We also provide training for supervisors and managers thr ough, among other things, the “Supervisor Training Manual.” The Company's educational and training materials include information on available methods of intervening when an alcohol or controlled substances problem is suspected, including confrontation,